Division of Plastic and Reconstructive Surgery, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA.
Craniofacial/Cleft Palate Program, Orthopaedic Institute for Children, Los Angeles, CA, USA.
Cleft Palate Craniofac J. 2025 Jan;62(1):13-20. doi: 10.1177/10556656231219439. Epub 2023 Dec 12.
To describe the long-term treatment course of bone-anchored maxillary protraction (BAMP) and evaluate orthognathic surgical indications after BAMP. Retrospective case series. Craniofacial/Cleft Palate Program at the Orthopaedic Institute for Children in Los Angeles, CA. Twelve male patients with cleft palate (CP), unilateral cleft lip and palate (UCLP), or bilateral cleft lip and palate (BCLP) and Class III malocclusion treated with BAMP (mean age: 11.4 ± 2.6 years) were included. BAMP treatment was performed by placement of bone-anchored maxillary and mandibular plates connected with intraoral Class III dental elastics or maxillary plates connected to a facemask. We retrospectively assessed BAMP treatment variables, including age at surgery, revision surgeries, and treatment duration. The primary goal was correction to class I occlusion. Twelve patients underwent BAMP treatment for an average of 4.4 ± 2.4 years. Two patients were corrected to class I occlusion at the time of this report. Le Fort I advancement was no longer required in two patients (16.7%), it was required for nine patients (75.0%) and was completed for one patient following BAMP treatment (8.3%). This preliminary report demonstrated that BAMP treatment may be associated with a minimal reduction in the requirement for Le Fort I advancement at skeletal maturity. Future studies with larger sample sizes are necessary to confirm this association.
描述骨锚定上颌骨牵引(BAMP)的长期治疗过程,并评估 BAMP 后的正颌手术适应证。回顾性病例系列。加利福尼亚州洛杉矶骨科研究所的颅面/腭裂计划。12 名男性患者患有腭裂(CP)、单侧唇腭裂(UCLP)或双侧唇腭裂(BCLP)和 III 类错颌,接受 BAMP 治疗(平均年龄:11.4±2.6 岁)。BAMP 治疗通过放置骨锚定上颌和下颌板并用口腔内 III 类牙齿弹性体或上颌板连接到面罩来进行。我们回顾性评估了 BAMP 治疗的变量,包括手术年龄、修正手术和治疗持续时间。主要目标是矫正为 I 类咬合。12 名患者接受 BAMP 治疗,平均持续 4.4±2.4 年。两名患者在本报告时被矫正为 I 类咬合。两名患者(16.7%)不再需要 Le Fort I 推进,九名患者(75.0%)需要进行 Le Fort I 推进,一名患者(8.3%)在 BAMP 治疗后完成。本初步报告表明,BAMP 治疗可能与骨骼成熟时 Le Fort I 推进需求的最小减少相关。需要更大样本量的未来研究来证实这种关联。